Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 31

Cited In for PubMed (Select 21112960)


Lysophosphatidic acid induces YAP-promoted proliferation of human corneal endothelial cells via PI3K and ROCK pathways.

Hsueh YJ, Chen HC, Wu SE, Wang TK, Chen JK, Ma DH.

Mol Ther Methods Clin Dev. 2015 Apr 29;2:15014. doi: 10.1038/mtm.2015.14. eCollection 2015.


A novel role for microRNA-129-5p in inhibiting ovarian cancer cell proliferation and survival via direct suppression of transcriptional co-activators YAP and TAZ.

Tan G, Cao X, Dai Q, Zhang B, Huang J, Xiong S, Zhang Yy, Chen W, Yang J, Li H.

Oncotarget. 2015 Apr 20;6(11):8676-86.


Hippo/YAP pathway for targeted therapy.

Felley-Bosco E, Stahel R.

Transl Lung Cancer Res. 2014 Apr;3(2):75-83. doi: 10.3978/j.issn.2218-6751.2014.02.03. Review.


A YAP/TAZ-Regulated Molecular Signature Is Associated with Oral Squamous Cell Carcinoma.

Hiemer SE, Zhang L, Kartha VK, Packer TS, Almershed M, Noonan V, Kukuruzinska M, Bais MV, Monti S, Varelas X.

Mol Cancer Res. 2015 Jun;13(6):957-68. doi: 10.1158/1541-7786.MCR-14-0580. Epub 2015 Mar 20.


The Hippo Coactivator YAP1 Mediates EGFR Overexpression and Confers Chemoresistance in Esophageal Cancer.

Song S, Honjo S, Jin J, Chang SS, Scott AW, Chen Q, Kalhor N, Correa AM, Hofstetter WL, Albarracin CT, Wu TT, Johnson RL, Hung MC, Ajani JA.

Clin Cancer Res. 2015 Jun 1;21(11):2580-90. doi: 10.1158/1078-0432.CCR-14-2191. Epub 2015 Mar 4.


YAP regulates the expression of Hoxa1 and Hoxc13 in mouse and human oral and skin epithelial tissues.

Liu M, Zhao S, Lin Q, Wang XP.

Mol Cell Biol. 2015 Apr;35(8):1449-61. doi: 10.1128/MCB.00765-14. Epub 2015 Feb 17.


YAP regulates S-phase entry in endothelial cells.

Shen Z, Stanger BZ.

PLoS One. 2015 Jan 30;10(1):e0117522. doi: 10.1371/journal.pone.0117522. eCollection 2015.


The role of the Hippo pathway in human disease and tumorigenesis.

Barron DA, Kagey JD.

Clin Transl Med. 2014 Jul 18;3:25. doi: 10.1186/2001-1326-3-25. eCollection 2014. Review.


Yes-associated protein (YAP) modulates oncogenic features and radiation sensitivity in endometrial cancer.

Tsujiura M, Mazack V, Sudol M, Kaspar HG, Nash J, Carey DJ, Gogoi R.

PLoS One. 2014 Jun 27;9(6):e100974. doi: 10.1371/journal.pone.0100974. eCollection 2014.


KRAS and YAP1 converge to regulate EMT and tumor survival.

Shao DD, Xue W, Krall EB, Bhutkar A, Piccioni F, Wang X, Schinzel AC, Sood S, Rosenbluh J, Kim JW, Zwang Y, Roberts TM, Root DE, Jacks T, Hahn WC.

Cell. 2014 Jul 3;158(1):171-84. doi: 10.1016/j.cell.2014.06.004. Epub 2014 Jun 19.


Yap1 activation enables bypass of oncogenic Kras addiction in pancreatic cancer.

Kapoor A, Yao W, Ying H, Hua S, Liewen A, Wang Q, Zhong Y, Wu CJ, Sadanandam A, Hu B, Chang Q, Chu GC, Al-Khalil R, Jiang S, Xia H, Fletcher-Sananikone E, Lim C, Horwitz GI, Viale A, Pettazzoni P, Sanchez N, Wang H, Protopopov A, Zhang J, Heffernan T, Johnson RL, Chin L, Wang YA, Draetta G, DePinho RA.

Cell. 2014 Jul 3;158(1):185-97. doi: 10.1016/j.cell.2014.06.003. Epub 2014 Jun 19.


Hippo coactivator YAP1 upregulates SOX9 and endows esophageal cancer cells with stem-like properties.

Song S, Ajani JA, Honjo S, Maru DM, Chen Q, Scott AW, Heallen TR, Xiao L, Hofstetter WL, Weston B, Lee JH, Wadhwa R, Sudo K, Stroehlein JR, Martin JF, Hung MC, Johnson RL.

Cancer Res. 2014 Aug 1;74(15):4170-82. doi: 10.1158/0008-5472.CAN-13-3569. Epub 2014 Jun 6.


Downstream of mutant KRAS, the transcription regulator YAP is essential for neoplastic progression to pancreatic ductal adenocarcinoma.

Zhang W, Nandakumar N, Shi Y, Manzano M, Smith A, Graham G, Gupta S, Vietsch EE, Laughlin SZ, Wadhwa M, Chetram M, Joshi M, Wang F, Kallakury B, Toretsky J, Wellstein A, Yi C.

Sci Signal. 2014 May 6;7(324):ra42. doi: 10.1126/scisignal.2005049.


Nicotine activates YAP1 through nAChRs mediated signaling in esophageal squamous cell cancer (ESCC).

Zhao Y, Zhou W, Xue L, Zhang W, Zhan Q.

PLoS One. 2014 Mar 12;9(3):e90836. doi: 10.1371/journal.pone.0090836. eCollection 2014.


Decreased expression of Yes-associated protein is associated with outcome in the luminal A breast cancer subgroup and with an impaired tamoxifen response.

Lehn S, Tobin NP, Sims AH, Stål O, Jirström K, Axelson H, Landberg G.

BMC Cancer. 2014 Feb 22;14:119. doi: 10.1186/1471-2407-14-119.


VGLL4 functions as a new tumor suppressor in lung cancer by negatively regulating the YAP-TEAD transcriptional complex.

Zhang W, Gao Y, Li P, Shi Z, Guo T, Li F, Han X, Feng Y, Zheng C, Wang Z, Li F, Chen H, Zhou Z, Zhang L, Ji H.

Cell Res. 2014 Mar;24(3):331-43. doi: 10.1038/cr.2014.10. Epub 2014 Jan 24.


YAP regulates cell proliferation, migration, and steroidogenesis in adult granulosa cell tumors.

Fu D, Lv X, Hua G, He C, Dong J, Lele SM, Li DW, Zhai Q, Davis JS, Wang C.

Endocr Relat Cancer. 2014 Mar 4;21(2):297-310. doi: 10.1530/ERC-13-0339. Print 2014 Apr.


Oncogenic function of SCCRO5/DCUN1D5 requires its Neddylation E3 activity and nuclear localization.

Bommeljé CC, Weeda VB, Huang G, Shah K, Bains S, Buss E, Shaha M, Gönen M, Ghossein R, Ramanathan SY, Singh B.

Clin Cancer Res. 2014 Jan 15;20(2):372-81. doi: 10.1158/1078-0432.CCR-13-1252. Epub 2013 Nov 5.


Aberrant activation, nuclear localization, and phosphorylation of Yes-associated protein-1 in the embryonic kidney and Wilms tumor.

Murphy AJ, Pierce J, de Caestecker C, Libes J, Neblett D, de Caestecker M, Perantoni AO, Tanigawa S, Anderson JR, Dome JS, Das A, Carroll TJ, Lovvorn HN 3rd.

Pediatr Blood Cancer. 2014 Feb;61(2):198-205. doi: 10.1002/pbc.24788. Epub 2013 Sep 20.


The hippo-yes association protein pathway in liver cancer.

Jie L, Fan W, Weiqi D, Yingqun Z, Ling X, Miao S, Ping C, Chuanyong G.

Gastroenterol Res Pract. 2013;2013:187070. doi: 10.1155/2013/187070. Epub 2013 Aug 6.

Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk